<DOC>
	<DOCNO>NCT01412450</DOCNO>
	<brief_summary>This study assess result 12 month Protégé EverFlex stent ( ev3 ) patient present narrow block level knee artery , lead limited walk distance , rest pain non-healing ulcer .</brief_summary>
	<brief_title>Efficacity Study With Protégé EverFlex Stent Popliteal Lesions</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>General Inclusion criterion De novo , restenotic reoccluded lesion locate popliteal artery , without superficial femoral artery involvement Patient present score 2 5 follow Rutherford classification Patient willing comply specify followup evaluation specify time Patient &gt; 18 year old Patient ( legal representative ) understand nature procedure provide write informed consent , prior enrolment study Prior enrollment , guidewire cross target lesion Patient eligible treatment selfexpanding nitinol EverFlex ( ev3 ) stent Angiographic Inclusion Criteria The target lesion angiographic evidence stenosis restenosis &gt; 50 % occlusion pass standard guidewire manipulation The target lesion , visually estimate , maximal length 14 cm categorize either type A B lesion accord TASC II guideline Target vessel diameter visually estimate &gt; 3.5mm &lt; 7.5 mm There angiographic evidence least onevesselrunoff foot Presence another stent target vessel place previous procedure Presence aortic thrombosis significant common femoral ipsilateral stenosis Previous bypass surgery limb Patients antiplatelet therapy , anticoagulant thrombolytic drug contraindicate Patients exhibit persistent acute intraluminal thrombus propose lesion site Perforation angioplasty site evidence extravasation contrast medium Patients know hypersensitivity nickeltitanium Patients uncorrected bleed disorder Aneurysm locate level SFA and/or popliteal artery Female patient child bear potential take adequate contraceptive currently breastfeed Life expectancy less twelve month Ipsilateral iliac treatment target lesion procedure residual stenosis &gt; 30 % ipsilateral iliac treatment conduct target lesion procedure Use thrombectomy , artherectomy laser device procedure Any patient consider hemodynamically unstable onset procedure Patient currently participate another investigational drug device study complete entire follow period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>symptomatic popliteal artery stenosis occlusion</keyword>
</DOC>